• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 4. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenyl sulfoxides

1-(Bromomethyl)-3-trifluoromethanesulfinylbenzene: A Versatile Building Block for Modern Organic Synthesis

In the realm of organic chemistry, 1-(bromomethyl)-3-trifluoromethanesulfinylbenzene (CAS No. 1263285-70-6) has emerged as a pivotal chemical intermediate with broad applications in pharmaceuticals, agrochemicals, and material science. This compound, characterized by its unique bromomethyl and trifluoromethanesulfinyl functional groups, offers exceptional reactivity, making it a sought-after reagent for C-C bond formation and cross-coupling reactions. Its molecular structure, C8H6BrF3OS, combines aromaticity with electrophilic and nucleophilic sites, enabling diverse synthetic transformations.

The growing demand for fluorinated compounds in drug discovery and advanced materials has propelled 1-(bromomethyl)-3-trifluoromethanesulfinylbenzene into the spotlight. Researchers and industries are increasingly exploring its potential in designing bioactive molecules, particularly in the development of kinase inhibitors and antiviral agents. A 2023 market analysis highlights a 12% annual growth in the utilization of such trifluoromethyl-containing intermediates, driven by their metabolic stability and lipophilicity enhancement in drug candidates.

From a synthetic perspective, the bromomethyl group in this compound serves as an excellent leaving group, facilitating nucleophilic substitutions, while the trifluoromethanesulfinyl moiety acts as both an electron-withdrawing group and a potential chiral auxiliary. This dual functionality enables the construction of complex molecular architectures through Palladium-catalyzed reactions or photoredox catalysis—two cutting-edge methodologies dominating contemporary organic synthesis. Recent publications in ACS Catalysis and Journal of Organic Chemistry have demonstrated its utility in constructing heterocyclic scaffolds for medicinal chemistry applications.

The compound's stability under ambient conditions and compatibility with common organic solvents (e.g., THF, DCM) make it particularly valuable for industrial-scale applications. Quality specifications typically require ≥98% purity (HPLC), with moisture content below 0.5% to ensure optimal performance in Grignard reactions or Suzuki-Miyaura couplings. Storage recommendations suggest maintaining the material at 2-8°C under inert atmosphere to preserve its reactivity.

Environmental and regulatory considerations have shaped the production processes for 1-(bromomethyl)-3-trifluoromethanesulfinylbenzene. Leading manufacturers now employ green chemistry principles, including solvent recovery systems and catalytic methods to minimize waste. The compound's REACH compliance status and well-documented safety data make it a preferred choice over traditional benzyl bromide derivatives in the European and North American markets.

Emerging applications in OLED materials and liquid crystals have further expanded the commercial potential of this intermediate. Its ability to introduce both electron-deficient aromatics and flexible linkers into π-conjugated systems makes it valuable for tuning electronic properties in optoelectronic devices. Patent analyses reveal a 40% increase in filings referencing this compound since 2020, particularly in organic semiconductor development.

For researchers seeking alternatives to hazardous reagents, 1-(bromomethyl)-3-trifluoromethanesulfinylbenzene offers a balance between reactivity and handling safety. Comparative studies show its superior performance over α-bromoacetophenone derivatives in asymmetric synthesis, with reduced byproduct formation. The compound's crystalline form at room temperature also simplifies purification procedures compared to liquid analogs.

The global supply chain for 1263285-70-6 remains robust, with major suppliers offering kilogram-scale quantities to support drug discovery programs. Pricing trends indicate moderate fluctuations tied to bromine market dynamics, though strategic stockpiling by pharmaceutical companies has maintained stable availability. Analytical methods including HPLC-MS and 19F NMR have been standardized for quality control across different production batches.

Future research directions likely involve exploiting the compound's potential in click chemistry and bioconjugation applications. Preliminary studies suggest its utility in creating fluorinated bioprobes for PET imaging, capitalizing on the trifluoromethanesulfinyl group's unique polarity profile. As synthetic methodologies continue evolving, 1-(bromomethyl)-3-trifluoromethanesulfinylbenzene will undoubtedly remain a cornerstone reagent for innovative chemical solutions.

• 21101-63-3(4-(Trifluoromethylthio)benzyl bromide)
• 261944-31-4(1-(bromomethyl)-3-(difluoromethyl)sulfanylbenzene)
• 866208-07-3(1-(Bromomethyl)-3-(trifluoromethylsulfonyl)benzene)
• 2189-43-7(Benzene,1-methyl-4-[(trifluoromethyl)sulfinyl]-)
• 1178899-45-0(1-methyl-3-trifluoromethanesulfinylbenzene)
• 213203-84-0(3-(Trifluoromethylthio)benzyl Bromide)
• 65325-67-9(1-[(fluoromethyl)sulfinyl]-4-methylbenzene)
• 118089-89-7(1-(bromomethyl)-4-trifluoromethanesulfonylbenzene)
• 885529-55-5(1-(Bromomethyl)-4-difluoromethanesulfonylbenzene)
• 1416276-99-7(1-methyl-3-trifluoromethanesulfonylbenzene)